Statistics for Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma
Total visits
| views | |
|---|---|
| Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma | 3 |
Total visits per month
| views | |
|---|---|
| May 2024 | 2 |
| June 2024 | 1 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| Jun2022PhaseII-CCBYNC.pdf | 1 |
Top country views
| views | |
|---|---|
| United States | 3 |
Top city views
| views | |
|---|---|
| Greenwood | 2 |
| Indianapolis | 1 |